Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-27
2008-05-27
Balasubram, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S236000
Reexamination Certificate
active
11016135
ABSTRACT:
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I:including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, R6, R7, m and n are described herein.
REFERENCES:
patent: 4515791 (1985-05-01), Allen et al.
patent: 6610694 (2003-08-01), Kawano et al.
patent: 2004/0063580 (2004-04-01), Kuragano et al.
patent: 1 120 418 (2001-08-01), None
patent: 1 568 398 (1980-05-01), None
patent: WO 00/20417 (2000-04-01), None
patent: WO 02/38562 (2002-05-01), None
patent: WO 2004/074259 (2004-09-01), None
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Petrocellis et al., British Journal of Pharmacology, 141, 765-774.
Black, Curr. Opin.. Investig. Drugs 5(4): 389-394, 2004.
U.S. Appl. No. 11/016,198, filed Dec. 17, 2004, Yu et al.
U.S. Appl. No. 11/015,876, filed Dec. 17, 2004, Ewing et al.
Deeb A. et al., “Studies on Polyazaindenes Synthesis of Several New Condensed Pyridazine Derivatives”, Collect. Czech. Chem. Commun., vol. 55 (11), pp. 2795-2799, 1990.
Patent Abstracts of Japan, vol. 010, No. 287 (C-375), Sep. 30, 1986 & JP 61 106576 (Nippon Soda Co. Ltd), May 24, 1986, Abstract; Claim 1, Table 1.
Database Beilstein, Beilstein Crossfire Iristitut Zur Foerderung Der Chemischen Wissenschaften; BRN 6750837 1994, XP002327081, abstract & Tarzia, G., et al., Benzodiazepine receptor ligands. Synthesis and preliminary pharmacological evaluation of 2-aminoalkyl-8-chloro- and 2-aryl-1,2,4-triazolo[3,4-a]phthalazine-3(2H)-ones. Farmaco (Societa Chimica Italiana: 1989) Jan. 1989, vol. 44, No. 1, (Jan. 1989), pp. 17-28, ISSN: 0014-827X.
Database Beilstein, Beilstein Crossfire Institut Zur Foerderung Der Chemischen Wissenschaften; BRN 9575107 2004, XP002327082, abstract & Wasfy, A.A.F., Journal Chem Res Miniprint, vol. 8, 2003, pp. 835-846.
Ellsworth Bruce A.
Ewing William R.
Gerritz Samuel
Gu Zhengxiang
Huang Yanting
Balasubram Venkataraman
Bristol--Myers Squibb Company
Gibbons Maureen S.
Miano Rosemary M.
LandOfFree
Azabicyclic heterocycles as cannabinoid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabicyclic heterocycles as cannabinoid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclic heterocycles as cannabinoid receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3956953